When your formulation demands the precision of a multi-particulate delivery system, the carrier you choose defines everything. CAPCEL™ Microcrystalline Cellulose Spheres by NB Entrepreneurs are engineered neutral pellets designed for formulators who need a sugar-free, starch-free, lactose-free base with exceptional sphericity, high mechanical strength, and the coating process resilience to withstand fluidised-bed and Wurster coating at scale. From controlled release to taste-masking, CAPCEL™ is the MCC sphere that makes complex formulations commercially viable.
CAPCEL™ MCC Spheres are highly spherical, inert pellets manufactured from pharmaceutical-grade Microcrystalline Cellulose. Unlike sugar spheres or starch-based pellets, CAPCEL™ contains no sugar, no lactose, and no starch — making it suitable for diabetic, lactose-intolerant, and sugar-free formulation requirements. The spheres are produced through a controlled extrusion-spheronisation process that delivers uniform, near-perfect spheres with a sphericity degree exceeding 90% on average. Their insoluble yet hydrophilic nature enables controlled water absorption during processing, reducing agglomeration even at high spray rates, while their high mechanical strength and very low friability ensure integrity through demanding coating processes.
Contains no sugar, lactose, or starch — suitable for diabetic patients, lactose-intolerant individuals, and clean-label supplement formulations.
Average sphericity degree above 90% ensures uniform film coating, predictable drug layering, and consistent dissolution profiles.
Withstands the mechanical stress of fluidised-bed and Wurster coating processes without fracturing or deforming.
Minimal particle breakage during coating and capsule filling — reducing waste, improving yield, and maintaining dose accuracy.
Absorbs water during coating and processing, reducing agglomeration at high spray rates for smoother coating operations.
Allows high drug-loading levels, enabling smaller capsule sizes and improved patient compliance.
Low chemical reactivity enables safe use with moisture-sensitive, high-potency, and chemically labile APIs.
Multi-particulate design reduces gastric emptying variability, minimises localised high drug concentrations, and lowers the risk of dose dumping.
Improves and simplifies the coating process — reducing coating defects and improving coating efficiency.
Sustained-release and controlled-release pellet formulations via functional coating
Taste-masking of bitter or unpleasant APIs via film or membrane coating
Enteric-coated pellet formulations for acid-sensitive APIs
Multi-unit pellet system (MUPS) tablet manufacturing
Immediate-release pellets with modified dissolution profiles
High-potency API layering with precise dose control
Pharmaceutical — solid dosage and modified-release formulation manufacturers
Generic drug manufacturers transitioning from single-unit to multi-particulate systems
Contract manufacturing organisations (CMOs) with Wurster/fluidised-bed coating capability
Nutraceutical brands requiring clean-label, sugar-free pellet carriers
Paediatric pharmaceutical formulators
With nearly five decades of manufacturing experience since 1976, cGMP-certified production facilities, and a track record serving 1,000+ customers across 192 cities and 20+ countries — including 75+ USFDA-accredited facilities — NB Entrepreneurs delivers CAPCEL™ — Microcrystalline Cellulose Spheres that meets the strictest pharmacopoeial standards. Our 18,000 MT/year MCC capacity ensures reliable bulk supply with 99.4% perfect order rate. Every batch ships with a full Certificate of Analysis, MSDS, and technical data sheet. Our dedicated technical team supports grade selection, formulation compatibility, and regulatory documentation — making us far more than just a supplier.
Microcrystalline Cellulose (MCC) spheres are used as inert, neutral pellet carriers in multi-particulate pharmaceutical formulations. APIs are layered onto the MCC sphere surface, which is then coated with functional films to control the rate, site, and timing of drug release. Common applications include sustained-release, controlled-release, enteric-coated, and taste-masked oral dosage forms.
CAPCEL™ MCC Spheres are manufactured entirely from Microcrystalline Cellulose — they contain no sugar, lactose, or starch. Sugar spheres are made from sucrose and starch, making them unsuitable for diabetic formulations and products requiring sugar-free or low-glycaemic claims. CAPCEL™ also offers superior mechanical strength and lower friability compared to sugar spheres, resulting in better coating process performance and higher yield.
CAPCEL™ MCC Spheres achieve an average sphericity degree greater than 90%. High sphericity ensures uniform film thickness during coating, consistent drug layering, and predictable dissolution profiles — all critical for the reproducibility of modified-release formulations.
Yes. CAPCEL™ MCC Spheres are specifically engineered to withstand the mechanical and thermal demands of Wurster fluidised-bed coating processes. Their high mechanical strength, low friability, and high abrasion resistance make them ideal for Wurster coating — enabling high coating efficiency with minimal particle fracture or agglomeration, even at elevated spray rates.